Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

γδ T cells adapt uniquely to different tissues in mice.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Skin bacteria can help wound healing by activating certain immune cells.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Clonally expanded CD8+ T cells cause alopecia areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.